According to the current analysis of Reports and Data, the Global Artificial urethra market is expected to reach USD 841.44 million by the year 2026, in terms of value at a CAGR of 12.5%. The efflux of urine is a common condition, which affects the patient's quality-of-life. Incontinence may arise as a consequence of a weakness of the urinary bladder or sphincter dysfunction, usually over-activity. The artificial urethra also called as artificial urinary sphincter consists of a cuff or ring that is placed around the urethra. There is a pump placed in the wall of the scrotum which can be manually squeezed. Upon squeezing the pump, fluid is shifted from the cuff to a balloon or reservoir that is placed behind the abdominal muscles.
Increase in investments in the market, which are supporting the technological advancements, and rise in healthcare expenditure are estimated to shape the growth of the artificial urethra market. The technological advancements in the artificial urethra include development of enhanced silicone rubber designs, advanced slings, and other flow securing devices. Due to these advancements in recent times, artificial urethras have demonstrated lesser adverse effects and greater efficacy and symptomatic relief in patients with prostate gland disorders as compared to conventional methods. Likewise, the potential benefits of artificial urethra therapy, such as long-term efficacy for 10 to 15 years, are projected to facilitate growth over the study period.
Furthermore, these advancements aid clinical researchers and physicians in investigational efficacy studies for the usage of artificial urethra off-label clinical applications such as prostate cancer. The flow Secure artificial urinary sphincter is a new prosthesis for the management of urinary incontinence due to Intrinsic urethral sphincter deficiency (ISD). Indications for implantation of the Flow Secure device in order of significance are post-prostatectomy urinary incontinence, incontinence due to congenital abnormalities, neurogenic bladder with ISD, and stress incontinence. The different and novel products in artificial urethra market designed for implantation in pediatric patients to treat deficient bladder sphincter function are expected to drive the demand of artificial urethra in the analysis period. The ZSI 375 for instance, has the advantage to increase the permitted pressure and allows the user to readjust the cuff. Various new types of the artificial sphincter are being developed using a spring-loaded mechanism for applying circumferential pressure in the urethra, which is easy to implant and simple to use. These product development initiatives undertaken by various companies are anticipated to bolster the artificial urethra market growth in the forecast period.
Market Overview:
The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviors are shifting in a variety of ways, from the growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.
Key Players covered in this report are
Boston Scientific Corporation, Zephyr Surgical Implants, GT Urological, Myopowers Medical Technologies SAS, and Promedon
By Product: (Revenue, USD Million; 2016-2026)
- Silicone elastomers
- Others
By Incontinence Type (Revenue, USD Million; 2016-2026)
- Stress Incontinence
- Urge Incontinence
- Overflow Incontinence
- Functional Incontinence
By Sales channel (Revenue, USD Million; 201-2026)
- Channel sales
- Direct sales
By End-user: (Revenue, USD Million; 2016-2026)
- Hospitals
- Specialty Clinics
- Research institutes
Based on Region market is segmented into:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East Africa
Request a sample Report on the Artificial Urethra Market @ https://www.reportsanddata.com/request-customization-form/1936
Major Points covered in this report are as below:
• The Artificial Urethra industry development trends and marketing channels are analyzed. The feasibility of new investment projects is assessed and overall research conclusions are offered.
• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
• Development policies and plans, manufacturing processes, and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue, and gross margins.
• The Artificial Urethra Market report provides key statistics on the market status of the Artificial Urethra manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problem provide our clients with the ability to secure an edge over their respective competitors.
